HealthScape Advisors Acquires PayerAlly for PBM Expertise

HealthScape Advisors, a prominent player in payer consulting and a subsidiary of Chartis, has significantly expanded its pharmacy benefit management (PBM) advisory capabilities through the strategic acquisition of PayerAlly. This move is designed to equip health plans and forward-thinking employers with enhanced tools to combat escalating prescription drug expenditures while fostering a more unified, clinically sound, and patient-centric approach to overall healthcare costs.

PayerAlly, established in 2022, has quickly carved out a niche as an independent authority in managing pharmacy and medical drug expenses. The firm offers integrated procurement services covering PBM, specialty pharmacy and infusion, and medical drug oversight. Their expertise also extends to auditing, vendor performance evaluation, and the development of data-driven clinical and pharmacy strategies. The leadership team, including Will McHugh, Bill Guerci, and Kerri Tanner, will continue to guide PayerAlly as a distinct division within HealthScape, preserving its specialized focus while leveraging the parent company's expanded technological resources and market reach.

The integration of these two entities promises a comprehensive service offering that spans both medical and pharmacy strategy. This combined strength will empower clients to more effectively manage high-cost medications, refine rebate and pricing negotiations, and implement robust PBM programs that strike a balance between cost containment and therapeutic innovation. Furthermore, the synergy is expected to accelerate the development of sophisticated analytics, integrated data frameworks, and technology-driven solutions tailored for the evolving needs of payers.

This strategic consolidation arrives at a critical juncture for the healthcare industry. Payers are navigating intense pressure to control soaring pharmacy costs, which represent one of the most dynamic and complex segments of healthcare spending. Simultaneously, they are tasked with improving patient outcomes and enhancing the member experience. HealthScape Advisors asserts that the combined organization is uniquely positioned to address these multifaceted challenges, offering a holistic perspective on total cost of care.

The healthcare advisory sector, particularly within specialized areas like pharmacy spend management, is experiencing robust growth. Chartis, a leading healthcare advisory firm serving over 1,900 organizations annually with more than 1,450 dedicated professionals, recognizes this trend. The acquisition of PayerAlly by HealthScape Advisors underscores the increasing demand for deep, specialized expertise as organizations seek to optimize their pharmacy benefit strategies in a rapidly changing market. This move aligns with the broader industry trend of consolidation among advisory firms aiming to offer more comprehensive solutions.

Dan Delaney, Managing Partner at HealthScape Advisors, highlighted the strategic rationale: “Payers are under increasing pressure to manage rising pharmacy costs while improving outcomes and member experience. PayerAlly brings deep, specialized expertise in PBM and specialty pharmacy strategy that complements our broader payer capabilities. Together, we can deliver more integrated, data-driven solutions that help clients improve affordability, enhance clinical value, and optimize total cost of care in a rapidly evolving healthcare marketplace.”

Echoing this sentiment, Will McHugh, Co-Founder of PayerAlly, stated: “We built PayerAlly to deliver independent, high-impact consulting in a market that demands rigor and innovation, challenging the traditional siloed approach and helping clients address rising medication costs through an emphasis on total cost of care. Joining HealthScape enables us to accelerate that mission, combining our analytics and pharmacy expertise with their deep payer insight to develop more scalable, technology-enabled solutions that drive meaningful clinical, operational, and financial outcomes.”